You'll come for the hands-on tweaking and wealth of features, and quickly forgive some of the workflow issues when you hear ...

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced the completion of enrollment and dosing in the dose-escalation portion of its first-in-human ...

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...

Because Krea relinquishes centralized control over the downstream deployment of its open weights, the contract legally binds ...

Abstract: A novel weighed and summing bipolar photonic digital-to-analog converter (BPDAC) scheme employing optical differential phase shift keying modulation and balanced detection is proposed and ...

Twelve seconds. That’s how long it takes to raise and retract the roof on the Porsche 911 GT3 S/C. It’s not a significant performance metric in this car, but it’s the only one that’s not improved over ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...